Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis

NCT00047827 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Inadequate enrollment

Conditions

Aspergillosis

Interventions

DRUG: Micafungin
DRUG: Liposomal Amphotericin B

Sponsor

Astellas Pharma Inc